This preliminary study supports further investigation of divalproexin the treatment of alcohol withdrawal.
2
The present study represents an open-label clinical trial comparing treatment with a benzodiazepine (lorazepam) to divalproexin 11 inpatients with uncomplicated alcohol withdrawal syndrome.